Cargando…

Drug repurposing on Alzheimer's disease through modulation of NRF2 neighborhood

Alzheimer's disease (AD) is an age-dependent neurodegenerative disorder and the most common cause of cognitive decline. The alarming epidemiological features of Alzheimer's disease, combined with the high failure rate of candidate drugs tested in the preclinical phase, impose more intense...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bourdakou, Marilena M., Fernández-Ginés, Raquel, Cuadrado, Antonio, Spyrou, George M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500459/ https://www.ncbi.nlm.nih.gov/pubmed/37696195 http://dx.doi.org/10.1016/j.redox.2023.102881

Ejemplares similares

Network-based stage-specific drug repurposing for Alzheimer’s disease
por: Savva, Kyriaki, et al.
Publicado: (2022)

Drug repurposing in idiopathic pulmonary fibrosis filtered by a bioinformatics-derived composite score
por: Karatzas, E., et al.
Publicado: (2017)

Systems Bioinformatics: increasing precision of computational diagnostics and therapeutics through network-based approaches
por: Oulas, Anastasis, et al.
Publicado: (2017)

Informed walks: whispering hints to gene hunters inside networks’ jungle
por: Bourdakou, Marilena M., et al.
Publicado: (2017)

Discovering gene re-ranking efficiency and conserved gene-gene relationships derived from gene co-expression network analysis on breast cancer data
por: Bourdakou, Marilena M., et al.
Publicado: (2016)

Preliminary In Vitro and In Vivo Insights of In Silico Candidate Repurposed Drugs for Alzheimer’s Disease
por: Savva, Kyriaki, et al.
Publicado: (2023)

PathWalks: identifying pathway communities using a disease-related map of integrated information
por: Karatzas, Evangelos, et al.
Publicado: (2020)

GeneStoryTeller: a mobile app for quick and comprehensive information retrieval of human genes
por: Eleftheriou, Stergiani V., et al.
Publicado: (2015)

Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development
por: Robledinos-Antón, Natalia, et al.
Publicado: (2019)

Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19
por: Tomazou, Marios, et al.
Publicado: (2021)

Vir2Drug: a drug repurposing framework based on protein similarities between pathogens
por: Minadakis, George, et al.
Publicado: (2022)

Generalized linear models provide a measure of virulence for specific mutations in SARS-CoV-2 strains
por: Oulas, Anastasis, et al.
Publicado: (2021)

An inhibitor of interaction between the transcription factor NRF2 and the E3 ubiquitin ligase adapter β-TrCP delivers anti-inflammatory responses in mouse liver
por: Fernández-Ginés, Raquel, et al.
Publicado: (2022)

Fibrotic expression profile analysis reveals repurposed drugs with potential anti-fibrotic mode of action
por: Karatzas, Evangelos, et al.
Publicado: (2021)

Transcription factor NRF2 uses the Hippo pathway effector TAZ to induce tumorigenesis in glioblastomas
por: Escoll, Maribel, et al.
Publicado: (2020)

Repurposing of Tibolone in Alzheimer’s Disease
por: Barreto, George E.
Publicado: (2023)

In silico repurposing of antipsychotic drugs for Alzheimer’s disease
por: Kumar, Shivani, et al.
Publicado: (2017)

Uncovering neuroinflammation-related modules and potential repurposing drugs for Alzheimer's disease through multi-omics data integrative analysis
por: Li, Shensuo, et al.
Publicado: (2023)

Anticancer drugs repurposed for Alzheimer’s disease: a systematic review
por: Ancidoni, Antonio, et al.
Publicado: (2021)

Machine learning identifies candidates for drug repurposing in Alzheimer’s disease
por: Rodriguez, Steve, et al.
Publicado: (2021)

Transcription factor NFE2L2/NRF2 modulates chaperone-mediated autophagy through the regulation of LAMP2A
por: Pajares, Marta, et al.
Publicado: (2018)

WIP Modulates Oxidative Stress through NRF2/KEAP1 in Glioblastoma Cells
por: Escoll, Maribel, et al.
Publicado: (2020)

Potential repurposing of oncology drugs for the treatment of Alzheimer's disease
por: Araki, Wataru
Publicado: (2013)

Repurposed agents in the Alzheimer’s disease drug development pipeline
por: Bauzon, Justin, et al.
Publicado: (2020)

Repurposing Licensed Drugs for Use Against Alzheimer’s Disease
por: Norins, Leslie C.
Publicado: (2021)

Single-cell-led drug repurposing for Alzheimer’s disease
por: Parolo, Silvia, et al.
Publicado: (2023)

NRF2 deficiency replicates transcriptomic changes in Alzheimer's patients and worsens APP and TAU pathology
por: Rojo, Ana I., et al.
Publicado: (2017)

Repurposing FDA‐Approved Compounds for the Discovery of Glutaminyl Cyclase Inhibitors as Drugs Against Alzheimer's Disease
por: Xu, Chenshu, et al.
Publicado: (2020)

Can Activation of NRF2 Be a Strategy against COVID-19?
por: Cuadrado, Antonio, et al.
Publicado: (2020)

Repurposing nitric oxide donating drugs in cancer therapy through immune modulation
por: Li, Chung-Yen, et al.
Publicado: (2023)

Modulation of proteostasis by transcription factor NRF2 and impact in neurodegenerative diseases
por: Pajares, Marta, et al.
Publicado: (2017)

Repurposing Diabetes Drugs for Brain Insulin Resistance in Alzheimer Disease
por: Yarchoan, Mark, et al.
Publicado: (2014)

Correction: Repurposed agents in the Alzheimer’s disease drug development pipeline
por: Bauzon, Justin, et al.
Publicado: (2023)

Modeling Path Importance for Effective Alzheimer’s Disease Drug Repurposing
por: Xiang, Shunian, et al.
Publicado: (2023)

Transcription Factor Nrf2: a novel target to modulate inflammatory and neuroprotective responses in Parkinson’s disease
por: Cuadrado, Antonio
Publicado: (2015)

Repurposing antihypertensive drugs for the prevention of Alzheimer’s disease: a Mendelian randomization study
por: Walker, Venexia M, et al.
Publicado: (2019)

ChemBioServer 2.0: an advanced web server for filtering, clustering and networking of chemical compounds facilitating both drug discovery and repurposing
por: Karatzas, Evangelos, et al.
Publicado: (2020)

Targeting abnormal metabolism in Alzheimer's disease: The Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study
por: Desai, Rishi J., et al.
Publicado: (2020)

Synthesize heterogeneous biological knowledge via representation learning for Alzheimer’s disease drug repurposing
por: Hsieh, Kang-Lin, et al.
Publicado: (2022)

Corrigendum to “An inhibitor of interaction between the transcription factor NRF2 and the E3 ubiquitin ligase adapter β-TrCP delivers anti-inflammatory responses in mouse liver” [Redox Biol. 55 (2022) 102396/PMID: 35839629]
por: Fernández-Ginés, Raquel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_np1td88q0d4u96tld1bbbnnf4c